STAGE III BREAST CANCER AJCC V7
Clinical trials for STAGE III BREAST CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III BREAST CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III BREAST CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Smart pill bottles and video calls tested to keep cancer patients on track
Disease control CompletedThis study tested whether technology could help breast cancer patients stick to their long-term hormone therapy. Researchers gave some patients smart pill bottles that sent reminders and others regular telehealth check-ins to discuss side effects. They wanted to see if these tool…
Matched conditions: STAGE III BREAST CANCER AJCC V7
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Major trial tests new weapon against spreading breast cancer
Disease control CompletedThis large, completed study tested whether adding an immunotherapy drug (atezolizumab) to a standard three-drug combination could better control advanced HER2-positive breast cancer that had spread. It involved 190 patients who were randomly assigned to receive either the new fou…
Matched conditions: STAGE III BREAST CANCER AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for tough breast cancers: 3-Drug combo tested before surgery
Disease control CompletedThis study tested whether adding a targeted drug (panitumumab) to two standard chemotherapy drugs could shrink tumors before surgery in patients with triple-negative breast cancer. The treatment was specifically for patients whose cancer didn't respond well to initial chemotherap…
Matched conditions: STAGE III BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC